Polymorphous light eruption (PLE) and new potent antioxidant and UVA-protective formulation as prophylaxis

Photodermatology Photoimmunology and Photomedicine

Volumn 20, Issue 4, 2004, Pages 200-204

  Hadshiew, I M ^a   Treder Condrad, C ^b   Bulow R V ^b   Klette, E ^b   Mann, T ^b   Stab F ^b   Moll, I ^a   Rippke, F ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b BEIERSDORF AG   (Germany)

Author keywords

Antioxidants; Clinical trial; Photoprovocation; Polymorphous light eruption; Sunscreens

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; DRUG VEHICLE; LADIVAL; LANOLIN ALCOHOL; RUTOSIDE DERIVATIVE; SUNSCREEN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; DRUG POTENCY; DRUG STRUCTURE; FEMALE; GEL; HUMAN; MALE; PHOTODERMATOSIS; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; SKIN PROTECTION; STATISTICAL SIGNIFICANCE; ULTRAVIOLET A RADIATION;

ADMINISTRATION, TOPICAL; ADULT; ALPHA-TOCOPHEROL; DERMATITIS, PHOTOALLERGIC; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; FLAVONOIDS; GELS; HUMANS; MALE; SUNSCREENING AGENTS; TREATMENT OUTCOME;

EID: 4043072066     PISSN: 09054383     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2004.00103.x     Document Type: Article

References (27)

1. McFadden JP, Norris PG, Cerio R, Orchard G, Hawk JL. Heat shock protein 65 immunoreactivity in experimentally induced polymorphic light eruption. Acta Derm Venereol 1994; 74: 283-285.
2. Norris P, Poston RN, Thomas DS, Thornhill M, Hawk J, Haskard DO. The expression of endothelial leukocyte adhesion molecule-1 (ELAM-1), intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in experimental cutaneous inflammation: a comparison of ultraviolet B erythema and delayed hypersensitivity. J Invest Dermatol 1991; 96: 763-770.
3. Norris PG, Barker JN, Allen MH, et al. Adhesion molecule expression in polymorphic light eruption. J Invest Dermatol 1992; 99: 504-508.
4. Krutmann J, Grewe M. Involvement of cytokines, DNA damage, and reactive oxygen intermediates in ultraviolet radiation-induced modulation of intercellular adhesion molecule-1 expression. J Invest Dermatol 1995; 105: 67s-70s.
5. Kölgen W, Van Weelden H, Den Hengst S, et al. CD11b+ cells and ultraviolet-B-resistant CD1a+ cells in skin of patients with polymorphous light eruption. J Invest Dermatol 1999; 113: 4-10.
6. Norris P, Bacon K, Bird C, Hawk J, Camp R. The role of interleukins 1, 6 and 8 as lymphocyte attractants in the photodermatoses polymorphic light eruption and chronic actinic dermatitis. Clin Exp Dermatol 1999; 24: 321-326.
7. Grether-Beck S, Olaizola-Horn S, Schmitt H, et al. Activation of transcription factor AP-2 mediates UVA radiation- and singlet oxygen-induced expression of the human intercellular adhesion molecule 1 gene. Proc Natl Acad Sci USA 1996; 93: 14586-14589.
8. Chen Y, Zheng R, Jia Z. Flavonoids as superoxide scavengers and antioxidants. Free Radic Biol Med 1990; 9: 19-21.
9. Stäb F, Wolber R, Blatt T, Keyhani R, Sauermann G. Topically applied antioxidants in skin protection. Methods Enzymol 2000; 319: 465.
10. Hadshiew I, Stäb F, Untiedt S, Bohnsack K, Rippke F, Hölzle E. Effects of topically applied antioxidants in experimentally provoked polymorphous light eruption. Dermatology 1997; 195: 362-368.
11. Rippke F, Wendt G, Bohnsack K, et al. Results of photoprovocation and field studies on the efficacy of a novel topically applied antioxidant in polymorphous light eruption. J Dermatolog Treat 2001; 12: 3-8.
12. Shipley DR, Hewitt JB. Polymorphic light eruption treated with cyclosporin. Br J Dermatol 2001; 144: 446-447.
13. Murphy GM, Hawk JL, Magnus IA. Hydroxychloroquine in polymorphic light eruption: a controlled trial with drug and visual sensitivity monitoring. Br J Dermatol 1987; 116: 379-386.
14. Murphy GM, Logan RA, Lovell CR, Morris RW, Hawk JL, Magnus IA. Prophylactic PUVA and UVB therapy in polymorphic light eruption-a controlled trial. Br J Dermatol 1987; 116: 531-538.
15. Stern RS. The risk of melanoma in association with long-term exposure to PUVA. J Am Acad Dermatol 2001; 44: 755-761.
16. Punnonen K, Autio P, Kiistala U, Ahotupa M. In-vivo effects of solar simulated ultraviolet irradiation on antioxidant enzymes and lipid peroxidation in human epidermis. Br J Dermatol 1991; 125: 18-20.
17. Morita A, Grewe M, Grether-Beck S, Olaizola-Horn S, Krutmann J. Induction of proinflammatory cytokines in human epidermoid carcinoma cells by in vitro ultraviolet A1 irradiation. Photochem Photobiol 1997; 65: 630-635.
18. Harman D. Role of free radicals in aging and disease. Ann N Y Acad Sci 1992; 673: 126-141.
19. Slater T. Free radical mechanisms in tissue injury. Biochem J 1984; 222: 1-15.
20. Leccia MT, Beani JC. Free radicals. Eur J Dermatol 1994; 4: 387-388.
21. Thiele JJ, Dreher F, Packer L. Antioxidant defense system in the skin. In: Elsner P, Maibach H, Rougier A, eds. Drugs vs cosmetics: cosmeceuticals. New York: Dekker, 2000; 145-187.
22. Shindo Y, Witt E, Han D, Epstein W, Packer L. Enzymic and non-enzymic antioxidants in epidermis and dermis of human skin. J Invest Dermatol 1994; 102: 122-124.
23. Robak J, Gryglewski RJ. Flavonoids are scavengers of superoxide anions. Biochem. Pharmacol 1988; 37: 837-841.
24. Stäb F, Wolber R, Mundt C, et al. Alpha-glucosylrutin - an innovative antioxidant in skin protection. SÖFW-J 2001; 127: 2-8.
25. Kootstra A. Protection from UV-B-induced DNA damage by flavonoids. Plant Mol Biol 1994; 26: 771-774.
26. McFadden N. UVA sensitivity and topical photoprotection in polymorphous light eruption. Photodermatol 1984; 1: 76-78.
27. Hadshiew IM, Eller MS, Gilchrest BA. Skin aging and photoaging: the role of DNA damage and repair. Am J Contact Dermat 2000; 11: 19-25.